RSV vaccine shows promise for cutting COPD attacks in High-Risk patients
NCT ID NCT07508644
First seen Apr 10, 2026 · Last updated May 09, 2026 · Updated 5 times
Summary
This study tests whether a respiratory syncytial virus (RSV) vaccine can reduce moderate-to-severe COPD flare-ups in people who have frequent attacks. Researchers will enroll 320 COPD patients who have had at least two flare-ups in the past year despite using standard inhalers. Half will get the RSV vaccine plus usual care, and half will get usual care alone. The goal is to see if the vaccine cuts flare-ups by at least 20% over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
Shatin, Hong Kong
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.